#ptsd

#ptsd

Psychedelic-assisted therapy may revolutionize treatment for PTSD, anxiety, and depression alongside innovations like transcranial magnetic stimulation.

Ketamine-Assisted Therapy used to treat PTSD in Ukrainian veterans.

The FDA's rejection of MDMA-AT marks another setback in PTSD treatment options, with no new drugs approved in 24 years.

The FDA has delayed the approval of MDMA-assisted therapy for PTSD, raising concerns but also prompting further research by the VA to validate its efficacy.

Psychedelic therapy offers potential hope for first responders suffering mental health crises. They seek healing for trauma, anxiety, and depression through innovative treatments.

The FDA's rejection of MDMA-assisted therapy for PTSD was a significant setback for MAPS and the psychedelic research community.

The war in Ukraine has led to a significant mental health crisis among civilians and soldiers, with millions needing support and treatment.

The Sagol Center uses hyperbaric oxygen therapy to effectively treat PTSD in survivors of the October 7 attack in Israel.

PTSD diagnoses among college students more than doubled from 2017 to 2022, attributed to societal stressors like the pandemic.

Athletes face significant trauma both in and out of sports, affecting their mental and physical well-being.

The prevalence of PTSD among athletes is notably higher than that in the general population.

Moncrieffe alleges the MTA's negligence contributed to his attack, claiming the assailant had a history of violence and was previously banned from the subway.

The Kansas City Chiefs faced panic during their Super Bowl parade due to gunfire, resulting in injuries and concerns for player safety.

A passenger was randomly assaulted on a United Airlines flight, highlighting concerns about in-flight safety.

The VA home loan program, designed to assist veterans, has unintentionally stranded many in high-cost mortgages, worsening financial burdens.

The FDA has authorized a clinical trial on marijuana's effectiveness for PTSD, marking a significant policy shift towards recognizing its therapeutic uses.

FDA rejects proposal to use MDMA for PTSD treatment

Derek Auguste's career as a veteran advocate stems from personal experiences with military service and the challenges of PTSD, highlighting the need for support systems.

A new study identifies a protective brain circuit associated with reduced PTSD development, challenging misconceptions about the disorder's links to moral character.

Breathing interventions can significantly reduce anxiety and PTSD symptoms in veterans, sometimes leading to lasting improvements even after short programs.

New online therapies endorsed by NHS could assist more individuals in overcoming anxiety and PTSD, particularly beneficial for children and adolescents.

Stress alters how memories are formed in the brain, leading to inappropriate fear responses in mice.

Dr. Ann Leader diagnosed Nikita Hand with PTSD, linking her symptoms to trauma from the alleged rape incident.

PTSD can lead to chronic anger or rage due to hyperalertness and emotional instability.

Factors contributing to PTSD anger include frustration, emotional instability, and hyperarousal.

Resentment can act as a psychological safeguard against PTSD.

People with PTSD experience persistent fear and anxiety.

Neurobiologists discovered a brain switch causing fear generalization.

The FDA did not approve MDMA for PTSD therapy, requiring an additional clinical trial.

MDMA-assisted psychotherapy is a promising treatment for PTSD and complex trauma, showing high efficacy and low dropout rates.

Avoidance is a key feature of PTSD but can worsen symptoms.

Reliance on avoidance may hinder recovery from PTSD.

Psychotherapies effectively address avoidance in PTSD treatment.

Unblinded trials compromise reliability, raising efficacy concerns for psychedelic therapy effectiveness in clinical studies.

MDMA for PTSD therapy efficacy is under FDA review due to flawed trials and safety concerns, marking a potential shift in federal policy.

FDA's proposed restrictions on MDMA for PTSD patients include monitoring safeguards and restricted administration at healthcare facilities.

FDA declines approval of MDMA for PTSD therapy, signaling cautious approach to psychedelics in medicine.

The FDA raised concerns about the use of MDMA for PTSD treatment due to flaws in studies and potential health risks.

Deepfakes are undermining the credibility of scientific research amidst challenges for Afghan scientists and setbacks in MDMA's approval for PTSD.

FDA's rejection of MDMA-assisted therapy signals a need for rigorous trial standards in psychedelic research, despite initial promising results.

The FDA rejected MDMA therapy for PTSD due to concerns about flawed clinical trials and biases in people involved, prompting retraction of supporting studies.

FDA declined to approve MDMA-assisted therapy for PTSD due to insufficient data, requesting additional clinical trials.

The FDA has requested further study on MDMA-assisted therapy for PTSD, dealing a blow to Lykos Therapeutics and the broader psychedelics movement.

The FDA will review the potential approval of ecstasy (MDMA) for treating PTSD, with promising trial results and a focus on LGBTQ+ individuals and those with certain health conditions.